H Joyce

697 total citations
20 papers, 551 citations indexed

About

H Joyce is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Oncology. According to data from OpenAlex, H Joyce has authored 20 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 7 papers in Physiology and 2 papers in Oncology. Recurrent topics in H Joyce's work include Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers), Asthma and respiratory diseases (7 papers) and Respiratory Support and Mechanisms (4 papers). H Joyce is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers), Asthma and respiratory diseases (7 papers) and Respiratory Support and Mechanisms (4 papers). H Joyce collaborates with scholars based in United Kingdom, Italy and New Zealand. H Joyce's co-authors include N. B. Pride, R G Taylor, F Holland, E.G. Gross, A Watson, Tow Keang Lim, Taylor Rg, Mark B. Pepys, N. B. Pride and Jacob Twiss and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and CHEST Journal.

In The Last Decade

H Joyce

18 papers receiving 518 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H Joyce United Kingdom 11 430 330 47 37 36 20 551
Bruno Sposato Italy 14 398 0.9× 306 0.9× 59 1.3× 10 0.3× 27 0.8× 56 639
Lawrence G. McAlpine United Kingdom 13 289 0.7× 119 0.4× 28 0.6× 34 0.9× 22 0.6× 19 452
Megan Hardin United States 15 832 1.9× 716 2.2× 32 0.7× 29 0.8× 12 0.3× 44 1.0k
Steen Nepper-Christensen Denmark 12 196 0.5× 332 1.0× 209 4.4× 30 0.8× 9 0.3× 16 480
Philippe Godard France 9 697 1.6× 739 2.2× 149 3.2× 20 0.5× 7 0.2× 12 909
Leonard Fromer United States 11 187 0.4× 263 0.8× 201 4.3× 9 0.2× 16 0.4× 26 447
Eva Martínez-Moragón Spain 11 415 1.0× 192 0.6× 51 1.1× 4 0.1× 21 0.6× 17 521
R H Green United Kingdom 3 496 1.2× 607 1.8× 92 2.0× 10 0.3× 10 0.3× 5 769
Christina Keen Sweden 13 923 2.1× 965 2.9× 126 2.7× 20 0.5× 54 1.5× 32 1.3k
Matthias Urban Austria 11 171 0.4× 147 0.4× 26 0.6× 10 0.3× 27 0.8× 28 314

Countries citing papers authored by H Joyce

Since Specialization
Citations

This map shows the geographic impact of H Joyce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Joyce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Joyce more than expected).

Fields of papers citing papers by H Joyce

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Joyce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Joyce. The network helps show where H Joyce may publish in the future.

Co-authorship network of co-authors of H Joyce

This figure shows the co-authorship network connecting the top 25 collaborators of H Joyce. A scholar is included among the top collaborators of H Joyce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Joyce. H Joyce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Conteduca, Vincenza, Simon J. Crabb, Robert J. Jones, et al.. (2016). Persistent Neutrophil to Lymphocyte Ratio >3 during Treatment with Enzalutamide and Clinical Outcome in Patients with Castration-Resistant Prostate Cancer. PLoS ONE. 11(7). e0158952–e0158952. 42 indexed citations
2.
Conteduca, Vincenza, Simon J. Crabb, Emanuela Scarpi, et al.. (2016). Association Between Early PSA Increase and Clinical Outcome in Patients Treated with Enzalutamide for Metastatic Castration Resistant Prostate Cancer. Molecular Diagnosis & Therapy. 20(3). 255–263. 8 indexed citations
3.
Conteduca, Vincenza, Simon J. Crabb, Emanuela Scarpi, et al.. (2016). Association between early PSA increase and clinical outcome in patients treated with enzalutamide for metastatic castration resistant prostate cancer.. Journal of Clinical Oncology. 34(2_suppl). 231–231. 1 indexed citations
4.
Giorgi, Ugo De, Simon J. Crabb, Robert J. Jones, et al.. (2015). High neutrophil to lymphocyte ratio (NLR) persistence during enzalutamide to predict poor clinical outcome in patients (pts) with metastatic castration-resistant prostate cancer (CRPC).. Journal of Clinical Oncology. 33(15_suppl). e16059–e16059. 3 indexed citations
5.
Munro, Karen, Peter Reed, H Joyce, et al.. (2010). Do New Zealand children with non‐cystic fibrosis bronchiectasis show disease progression?. Pediatric Pulmonology. 46(2). 131–138. 31 indexed citations
6.
Joyce, H, et al.. (2005). Evolution of changes in carbon monoxide transfer factor in men with chronic obstructive pulmonary disease. Respiratory Medicine. 99(8). 1053–1060. 6 indexed citations
7.
Watson, A, H Joyce, & N. B. Pride. (2000). Changes in carbon monoxide transfer over 22 years in middle-aged men. Respiratory Medicine. 94(11). 1103–1108. 8 indexed citations
8.
Watson, A, et al.. (1993). Influence of smoking habits on change in carbon monoxide transfer factor over 10 years in middle aged men.. Thorax. 48(2). 119–124. 20 indexed citations
9.
Watson, A, Tow Keang Lim, H Joyce, & N. B. Pride. (1992). Failure of Inhaled Corticosteroids to Modify Bronchoconstrictor or Bronchodilator Responsiveness in Middle-Aged Smokers with Mild Airflow Obstruction. CHEST Journal. 101(2). 350–355. 48 indexed citations
10.
Hind, C R, H Joyce, Glenys A. Tennent, Mark B. Pepys, & N. B. Pride. (1991). Plasma leucocyte elastase concentrations in smokers.. Journal of Clinical Pathology. 44(3). 232–235. 21 indexed citations
11.
12.
Turner, Nicholas C., et al.. (1990). Effects of nonsteroidal anti-inflammatory drugs on the bronchial hyperresponsiveness of middle-aged male smokers. European Respiratory Journal. 3(8). 872–879. 3 indexed citations
13.
Watson, A, et al.. (1989). Effects of smoking on changes in respiratory resistance with increasing age. Clinical Science. 76(5). 487–494. 23 indexed citations
14.
Barter, S., et al.. (1988). Abnormal Regional Distribution of Ventilation in Middle-Aged Smokers. Clinical Science. 74(s18). 36P–36P.
15.
Rg, Taylor, et al.. (1988). Bronchial hyperresponsiveness as a risk factor for progressive airflow obstruction in smokers.. PubMed. 23(4). 369–75. 37 indexed citations
16.
Lim, Tow Keang, R G Taylor, A Watson, H Joyce, & N. B. Pride. (1988). Changes in bronchial responsiveness to inhaled histamine over four years in middle aged male smokers and ex-smokers.. Thorax. 43(8). 599–604. 28 indexed citations
17.
Burr, Michael, Jonathan G.L. Mullins, Alastair Watson, et al.. (1985). Proceedings of the British Thoracic Society. 1985 summer meeting. 3-5 July, York. Abstracts.. Thorax. 40(9). 688–728. 9 indexed citations
18.
Taylor, R G, E.G. Gross, H Joyce, F Holland, & N. B. Pride. (1985). Smoking, allergy, and the differential white blood cell count.. Thorax. 40(1). 17–22. 79 indexed citations
19.
Taylor, R G, H Joyce, E.G. Gross, F Holland, & N. B. Pride. (1985). Bronchial reactivity to inhaled histamine and annual rate of decline in FEV1 in male smokers and ex-smokers.. Thorax. 40(1). 9–16. 144 indexed citations
20.
Taylor, R G, et al.. (1984). Relation Between Bronchial Reactivity to Inhaled Histamine and Annual Decline in FEV 1 in Male Smokers and Exsmokers. CHEST Journal. 85(6). 22S–22S. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bruno Sposato Breakdown of academic impact, for papers by Lawrence G. McAlpine Breakdown of academic impact, for papers by Megan Hardin Breakdown of academic impact, for papers by Steen Nepper-Christensen Breakdown of academic impact, for papers by Philippe Godard Breakdown of academic impact, for papers by Leonard Fromer Breakdown of academic impact, for papers by Eva Martínez-Moragón Breakdown of academic impact, for papers by R H Green Breakdown of academic impact, for papers by Christina Keen Breakdown of academic impact, for papers by Matthias Urban
Rankless by CCL
2026